国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Development and Evaluation of Curcumin Emulgel with Cumin Oil for Topical Application

Krishna Kumar

In this research, Emulgel of curcumin was developed by using Carbopol 940 as a gelling agent. Curcumin is a hydrophobic natural origin drug and Emulgel can suitably deliver hydrophobic drugs. Therefore this is a challenging task for the administration of curcumin through the skin. During the development of Emulgel, curcumin was rarely solubilized in the water phase, so firstly we dissolve them in ethanol and dispersed them in the water phase. Curcumin is the natural origin drug obtained from Curcuma longa, they have a broad number of activities like antifungal, antibacterial, anti-inflammatory, anticancer, etc. Curcumin is a well-identified herbal-origin drug by traditional medicine scriptures. It is well established for the cure of various ailments including cancer, fungal infection, and bacterial infection. However, the natural origin drug imparts a bioavailability problem. To overcome this obstacle the emulgel was developed. Emulgel was developed by adding the oil phase into the aqueous phase by continuous stirring. Therefore the gel phase was developed by dissolving Carbopol 940 in purified distilled water followed by gentle heat on a magnetic stirrer, finally developed emulsion and gel was mixed (1:1 ratio) properly by the propellant mixer. In the Preformulation study solubility, PH, color, FTIR of curcumin were analyzed properly. Further, all the developed formulations were evaluated for their PH, physical characteristics, spreadability, phase separation, in-vitro drug release, drug content, and viscosity, etc. After a study of all obtained results, it was founded that formulation F2 and F4 best in all prospects. The viscosity of F2 and F4 was 12600 Centipoise and 11400 Centipoise respectively. The % release of the drug from Emulgel formulation was 80-95%. Finally, F2 and F4 were decided as an optimized formulation for the final formulation. The drug content of all developed formulations was founded to be 83-90%. Also after 3 months, the drug content should maintain the formulation. From this study we say that Emulgel is an appropriate topical drug delivery system as compared to another already available topical dosage form, Emulgel has the best spreadability and adhesive property therefore it is suitable for dermal application. To know the detailed antibacterial activity and irritability property of curcumin Emulgel there is a need for in vivo study in the future.